Mei Wu
ORCID: 0000-0002-2467-1402
· 5 papers in corpus
other
2025
OBJECTIVE: Observational studies suggest that blood lipids are a risk factor for uterine fibroids (UFs) and that lipid-lowering drugs are beneficial for the treatment and prevention of UF; however, the conclusions are inconsistent. We aimed…
other
2025
OBJECTIVE: This study aims to analyze and summarize the clinical characteristics of small intestinal adenomyosis. METHODS: A retrospective study was conducted on children with small intestinal adenomyosis at our center from 2014 to 2024. T…
observational
2022
AIM: To classify the FIGO's PALM-COEIN etiology for abnormal uterine bleeding (AUB) patients according to the ultrasound and histopathology and to evaluate the etiology prevalence distribution for AUB patients. METHODS: A total of 1065 wom…
observational
2012
BACKGROUND: In premenopausal women, endocrine adjuvant therapy for breast cancer primarily consists of tamoxifen alone or with ovarian suppressive strategies. Toremifene is a chlorinated derivative of tamoxifen, but with a superior risk-ben…
lab-animal
2011
OBJECTIVE: To investigate the inhibitory effect of gonadotropin-releasing hormone II(GnRHII) and gonadotropin-releasing hormone I agonist (GnRH Ia) on the proliferation of endometrial stromal cells in vitro from endometriosis patients. MET…